BL-1022

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBL-1022
Drug Alias Nameneurotransmission modulator (BioLineRx)BL-1022
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurotransmitter modulators
TargetsNeurotransmitter
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiolinerx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolinerx Ltd
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A